Strategic Financial Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$212K Hold
725
0.01% 145
2025
Q4
$246K Sell
725
-459
-39% -$155K 0.01% 128
2025
Q3
$383K Sell
1,184
-70
-6% -$21.8K 0.02% 105
2025
Q2
$488K Hold
1,254
0.03% 93
2025
Q1
$545K Sell
1,254
-204
-14% -$81.9K 0.03% 84
2024
Q4
$538K Sell
1,458
-325
-18% -$136K 0.03% 89
2024
Q3
$927K Sell
1,783
-195
-10% -$104K 0.06% 63
2024
Q2
$1.07M Sell
1,978
-105
-5% -$55.5K 0.07% 59
2024
Q1
$1.08M Sell
2,083
-1,754
-46% -$872K 0.07% 59
2023
Q4
$1.81M Sell
3,837
-553
-13% -$256K 0.13% 43
2023
Q3
$1.91M Sell
4,390
-44
-1% -$20K 0.15% 43
2023
Q2
$2.04M Sell
4,434
-56
-1% -$25.8K 0.15% 45
2023
Q1
$2.06M Sell
4,490
-237
-5% -$113K 0.16% 45
2022
Q4
$2.42M Sell
4,727
-367
-7% -$186K 0.19% 43
2022
Q3
$2.31M Sell
5,094
-237
-4% -$113K 0.2% 43
2022
Q2
$2.57M Sell
5,331
-500
-9% -$247K 0.22% 46
2022
Q1
$2.86M Sell
5,831
-130
-2% -$59.4K 0.22% 49
2021
Q4
$2.76M Sell
5,961
-148
-2% -$62.3K 0.21% 55
2021
Q3
$2.28M Sell
6,109
-143
-2% -$54.3K 0.18% 57
2021
Q2
$2.39M Sell
6,252
-97
-2% -$37.1K 0.19% 59
2021
Q1
$2.28M Sell
6,349
-635
-9% -$204K 0.19% 60
2020
Q4
$2.24M Sell
6,984
-90
-1% -$27.6K 0.2% 63
2020
Q3
$1.9M Sell
7,074
-300
-4% -$80.7K 0.2% 62
2020
Q2
$1.94M Sell
7,374
-3,726
-34% -$994K 0.22% 63
2020
Q1
$2.52M Sell
11,100
-1,792
-14% -$488K 0.34% 58
2019
Q4
$3.89M Sell
12,892
-2,193
-15% -$603K 0.45% 62
2019
Q3
$3.62M Sell
15,085
-8,910
-37% -$2.44M 0.46% 67
2019
Q2
$6.77M Sell
23,995
-575
-2% -$157K 0.89% 25
2019
Q1
$7.05M Sell
24,570
-680
-3% -$197K 0.97% 24
2018
Q4
$6.63M Buy
25,250
+35
+0.1% +$9.62K 1.04% 20
2018
Q3
$6.91M Sell
25,215
-980
-4% -$254K 1.03% 18
2018
Q2
$6.24M Buy
26,195
+190
+0.7% +$44K 0.96% 19
2018
Q1
$5.71M Sell
26,005
-155
-0.6% -$36.4K 0.93% 20
2017
Q4
$5.89M Sell
26,160
-95
-0.4% -$20.2K 0.93% 18
2017
Q3
$4.99M Buy
26,255
+45
+0.2% +$8.56K 0.82% 26
2017
Q2
$4.93M Sell
26,210
-20
-0.1% -$3.59K 0.86% 26
2017
Q1
$4.34M Sell
26,230
-615
-2% -$97.8K 0.79% 30
2016
Q4
$3.86M Sell
26,845
-195
-0.7% -$26.1K 0.74% 37
2016
Q3
$3.39M Buy
27,040
+150
+0.6% +$19.4K 0.67% 48
2016
Q2
$3.53M Buy
26,890
+439
+2% +$60.1K 0.71% 42
2016
Q1
$3.68M Buy
26,451
+741
+3% +$99K 0.85% 30
2015
Q4
$3.58M Buy
25,710
+595
+2% +$82K 0.94% 34
2015
Q3
$3.52M Buy
25,115
+670
+3% +$101K 0.97% 30
2015
Q2
$4.01M Sell
24,445
-455
-2% -$72.7K 1.13% 20
2015
Q1
$3.85M Sell
24,900
-190
-0.8% -$27.1K 0.99% 31
2014
Q4
$3.15M Buy
25,090
+35
+0.1% +$4.33K 0.86% 52
2014
Q3
$3M Buy
25,055
+25
+0.1% +$2.87K 0.84% 55
2014
Q2
$2.69M Sell
25,030
-7,985
-24% -$823K 0.75% 65
2014
Q1
$3.29M Buy
33,015
+1,605
+5% +$145K 0.96% 33
2013
Q4
$2.9M Sell
31,410
-565
-2% -$50.2K 0.92% 37
2013
Q3
$2.67M Sell
31,975
-745
-2% -$63.8K 0.9% 38
2013
Q2
$2.68M Buy
+32,720
New +$2.45M 0.95% 35

Other funds holding ELV

Strategic Financial Services's ELV Position: Q1 2026 in Review

Strategic Financial Services held its Elevance Health (ELV) position steady in Q1 2026 at 725 shares worth $212K. The position accounts for 0.01% of the portfolio, ranked #145.

Strategic Financial Services first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.05M in Q1 2019. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Strategic Financial Services held 725 shares of Elevance Health worth $212K as of Q1 2026.
  • Strategic Financial Services left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up 0.01% of Strategic Financial Services's portfolio in Q1 2026, its #145 holding.
  • Strategic Financial Services first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Strategic Financial Services's Elevance Health position peaked at $7.05M in Q1 2019.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Strategic Financial Services's 13F filing for Q1 2026, filed 8 May 2026.